Symantec AntiVirus SAVRT.SYS Local Privilege Escalation Vulnerability

BID:20684

Info

Symantec AntiVirus SAVRT.SYS Local Privilege Escalation Vulnerability

Bugtraq ID: 20684
Class: Boundary Condition Error
CVE: CVE-2006-3455
Remote: No
Local: Yes
Published: Oct 23 2006 12:00AM
Updated: Oct 24 2006 07:28PM
Credit: Boon Seng Lim is credited with the discovery of this vulnerability.
Vulnerable: Symantec Client Security 2.0.4
Symantec Client Security 2.0.3 MR3 b9.0.3.1000
Symantec Client Security 2.0.2 MR2 b9.0.2.1000
Symantec Client Security 2.0.1 MR1 b9.0.1.1000
Symantec Client Security 2.0 STM build 9.0.0.338
Symantec Client Security 2.0 (SCF 7.1)
Symantec Client Security 2.0 (SCF 7.1)
Symantec Client Security 2.0
Symantec Client Security 1.1.1
Symantec Client Security 1.1 STM b8.1.0.825a
Symantec Client Security 1.1
Symantec Client Security 1.0.1 MR8 build 8.01.471
Symantec Client Security 1.0.1 MR7 build 8.01.464
Symantec Client Security 1.0.1 MR6 build 8.01.460
Symantec Client Security 1.0.1 MR5 build 8.01.457
Symantec Client Security 1.0.1 MR4 build 8.01.446
Symantec Client Security 1.0.1 MR3 build 8.01.434
Symantec Client Security 1.0.1 build 8.01.437
Symantec Client Security 1.0.1 MR9 b8.01.501
Symantec Client Security 1.0.1 MR2 b8.01.429c
Symantec Client Security 1.0.1 MR1 b8.01.425a/b
Symantec Client Security 1.0.1
Symantec Client Security 1.0 .0 b8.01.9378
Symantec Client Security 1.0 b8.01.9374
Symantec Client Security 1.0
Symantec AntiVirus Corporate Edition 9.0.3 .1000
Symantec AntiVirus Corporate Edition 9.0.2 .1000
Symantec AntiVirus Corporate Edition 9.0.1 .1.1000
Symantec AntiVirus Corporate Edition 9.0 .0.338
Symantec AntiVirus Corporate Edition 9.0
Symantec AntiVirus Corporate Edition 8.1.1 build 8.1.1.329
Symantec AntiVirus Corporate Edition 8.1.1 build 8.1.1.323
Symantec AntiVirus Corporate Edition 8.1.1 build 8.1.1.319
Symantec AntiVirus Corporate Edition 8.1.1 build 8.1.1.314a
Symantec AntiVirus Corporate Edition 8.1.1 build 393
Symantec AntiVirus Corporate Edition 8.1.1 .377
Symantec AntiVirus Corporate Edition 8.1.1 .366
Symantec AntiVirus Corporate Edition 8.1.1
Symantec AntiVirus Corporate Edition 8.1 build 8.01.471
Symantec AntiVirus Corporate Edition 8.1 build 8.01.464
Symantec AntiVirus Corporate Edition 8.1 build 8.01.460
Symantec AntiVirus Corporate Edition 8.1 build 8.01.457
Symantec AntiVirus Corporate Edition 8.1 build 8.01.446
Symantec AntiVirus Corporate Edition 8.1 build 8.01.437
Symantec AntiVirus Corporate Edition 8.1 build 8.01.434
Symantec AntiVirus Corporate Edition 8.1 .0.825a
Symantec AntiVirus Corporate Edition 8.1
Not Vulnerable: Symantec Client Security 2.0.4 MR4 build 1000
Symantec Client Security 1.1.1 MR9 Build 393
Symantec AntiVirus Corporate Edition 9.0.4 MR4 build 1000
Symantec AntiVirus Corporate Edition 8.1.1 MR9

Discussion

Symantec AntiVirus SAVRT.SYS Local Privilege Escalation Vulnerability

Symantec AntiVirus and Symantec Client Security are prone to a privilege-escalation vulnerability.

Local attackers can exploit this issue to corrupt memory and execute arbitrary code with kernel-level privileges. Successful exploits may facilitate a complete system compromise.

This issue affects:

- Symantec AntiVirus Corporate Edition
- Symantec Client Security.

Exploit / POC

Symantec AntiVirus SAVRT.SYS Local Privilege Escalation Vulnerability

Currently we are not aware of any exploits for this issue. If you feel we are in error or if you are aware of more recent information, please mail us at: [email protected] <mailto:[email protected]>.

Solution / Fix

Symantec AntiVirus SAVRT.SYS Local Privilege Escalation Vulnerability

Solution:
Symantec has released security advisory SYM06-022 to address this issue. Please see the referenced advisory for more information.

References

Symantec AntiVirus SAVRT.SYS Local Privilege Escalation Vulnerability

References:

© CVE.report 2026

Use of this information constitutes acceptance for use in an AS IS condition. There are NO warranties, implied or otherwise, with regard to this information or its use. Any use of this information is at the user's risk. It is the responsibility of user to evaluate the accuracy, completeness or usefulness of any information, opinion, advice or other content. EACH USER WILL BE SOLELY RESPONSIBLE FOR ANY consequences of his or her direct or indirect use of this web site. ALL WARRANTIES OF ANY KIND ARE EXPRESSLY DISCLAIMED. This site will NOT BE LIABLE FOR ANY DIRECT, INDIRECT or any other kind of loss.

CVE, CWE, and OVAL are registred trademarks of The MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. This site includes MITRE data granted under the following license.

Free CVE JSON API cve.report/api

CVE.report and Source URL Uptime Status status.cve.report